Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04641871
Title Sym021 in Combination With Either Sym022 or Sym023 in Patients With Advanced Solid Tumor Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Symphogen A/S
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | CAN


No variant requirements are available.